<DOC>
	<DOCNO>NCT00335244</DOCNO>
	<brief_summary>This clinical trial determine safety effectiveness intravenous L-citrulline child undergo cardiopulmonary bypass heart surgery . Participants randomly assign either L-citrulline placebo ( substance medicine ) . Citrulline protein build block body convert another substance , nitric oxide ( NO ) , control blood pressure lung . Increased blood pressure lung important surgical problem ; may also lead problem follow surgery , severe high blood pressure lung ( pulmonary hypertension ) , increased time spent breathing machine , long stay intensive care unit ( ICU ) . The hypothesis study perioperative supplementation intravenous citrulline increase plasma citrulline , arginine NO metabolite prevent elevation postoperative PVT lead decrease duration postoperative invasive mechanical ventilation .</brief_summary>
	<brief_title>Intravenous L-Citrulline Treat Children Undergoing Heart Bypass Surgery</brief_title>
	<detailed_description>Increased pulmonary vascular tone ( PVT ) complicate postoperative course follow five surgical procedure congenital heart defect : 1 ) unrestrictive ventricular septal defect ( VSD ) repair ; 2 ) atrioventricular septal ( AVSD ) repair ; 3 ) arterial switch procedure transposition great artery ( TGA ) ; 4 ) bidirectional Glenn shunt procedure ; 5 ) Fontan procedure single ventricle lesion . PVT partially control NO . Arginine , precursor NO , product urea cycle . Preliminary data present regard 169 infant child undergo one six previous surgical procedure . It find urea cycle function plasma arginine level significantly decrease participant . Furthermore , participant increase PVT significantly low arginine level compare participant normal PVT . Finally , genetic single nucleotide polymorphism ( SNP ) rate limit urea cycle enzyme ( carbamyl phosphate synthetase I [ CPSl T1405N ] ) appear affect postoperative plasma arginine level PVT . The hypothesis genetic polymorphism rate limit urea cycle enzyme CPSl , important enzyme urea cycle , influence availability NO precursor . It hypothesize perioperative enhancement urea cycle function key urea cycle intermediate ( citrulline ) increase plasma arginine NO metabolite prevent elevation PVT .</detailed_description>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Undergoing cardiopulmonary bypass surgery 1 follow 5 procedure : 1 . AVSD repair 2 . VSD repair 3 . Bidirectional Glenn 4 . Modified Fontan 5 . Arterial switch Pulmonary artery vein abnormality address surgically Preoperative requirement mechanical ventilation intravenous inotrope support Any condition might interfere study objective , determine investigator Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>